Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection

Gillian Kinnear, Kathryn J Wood, Diane Marshall, Nicholas Jones

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)
376 Downloads (Pure)

Abstract

OX40 is a member of the tumor necrosis factor receptor superfamily and is a potent T-cell costimulatory molecule. Although the impact of blockade of the OX40-OX40L pathway has been documented in models of autoimmune disease, the effect on allograft rejection is less well defined.
Original languageEnglish
Pages (from-to)1265-71
Number of pages7
JournalTransplantation
Volume90
Issue number12
DOIs
Publication statusPublished - 27 Dec 2010

Fingerprint

Dive into the research topics of 'Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection'. Together they form a unique fingerprint.

Cite this